Literature DB >> 7813606

Molecular cloning of a cDNA encoding for the GLP-1 receptor expressed in rat lung.

B Lankat-Buttgereit1, R Göke, H C Fehmann, G Richter, B Göke.   

Abstract

Recent data revealed the existence, localization and possible function of specific receptors for glucagon-like peptide 1 (7-36) amide (GLP-1) in rat lung. This receptor has different biochemical features than the GLP-1 receptor in endocrine pancreas. Therefore, we aimed to clone the lung receptor cDNA in order to analyze whether biochemical and functional diversity of the GLP-1 receptors in lung and pancreas is based upon genetic differences. A cDNA library from rat lung in a lambda gt11 vector was screened with a cDNA probe coding for the rat pancreas GLP-1 receptor. Thereby, we found a lung GLP-1 receptor cDNA which shows nearly complete homology to the pancreatic beta-cell receptor cDNA. Only one base exchange occurred at base 1 of a codon at position 977 resulting in a change of valine residue for isoleucine at position 323 of the amino acid sequence within the fifth transmembrane region. Northern blot hybridization identified transcripts at 2.7, 3.4, and 3.6 Kb. Expression of the recombinant lung GLP-1 receptor cDNA in CHO cells displayed a pharmacological profile similar to that seen with cells expressing the beta-cell derived cDNA. Therefore, we conclude that tissue-specificity for GLP-1 receptors is based upon posttranslational modifications of the receptor protein (for example glycosilation) or alternative splicing of primary transcripts and not on variations within the coding sequence of the receptor gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7813606     DOI: 10.1055/s-0029-1211301

Source DB:  PubMed          Journal:  Exp Clin Endocrinol        ISSN: 0232-7384


  6 in total

Review 1.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

Review 2.  The gut and food intake: an update for surgeons.

Authors:  E Näslund; P M Hellström; J G Kral
Journal:  J Gastrointest Surg       Date:  2001 Sep-Oct       Impact factor: 3.452

Review 3.  The effect of glucagon-like peptide 1 on cardiovascular risk.

Authors:  Jacob Sivertsen; Jaya Rosenmeier; Jens J Holst; Tina Vilsbøll
Journal:  Nat Rev Cardiol       Date:  2012-01-31       Impact factor: 32.419

Review 4.  GLP-1: benefits beyond pancreas.

Authors:  G Muscogiuri; A Cignarelli; F Giorgino; F Prodam; F Prodram; D Santi; G Tirabassi; G Balercia; R Modica; A Faggiano; A Colao
Journal:  J Endocrinol Invest       Date:  2014-08-09       Impact factor: 4.256

5.  Interaction of glucagon-like peptide-I (GLP-I) and galanin in insulin (beta TC-1)- and somatostatin (RIN T3)-secreting cells and evidence that both peptides have no receptors on glucagon (INR1G9)-secreting cells.

Authors:  H C Fehmann; M Janssen; B Göke
Journal:  Acta Diabetol       Date:  1995-10       Impact factor: 4.280

6.  GLP-1 Receptor Signaling Differentially Modifies the Outcomes of Sterile vs Viral Pulmonary Inflammation in Male Mice.

Authors:  Takehiro Sato; Tatsunori Shimizu; Hiroki Fujita; Yumiko Imai; Daniel J Drucker; Yutaka Seino; Yuichiro Yamada
Journal:  Endocrinology       Date:  2020-12-01       Impact factor: 4.736

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.